Gilead Sciences Farmacêutica do Brasil Ltda.

Avenida Doutor Chucri Zaidan, 1240, Cj. 1501-1502 - 15º andar
Golden Tower - Morumbi Corporate
04711-130 São Paulo-SP- Brasil

Phone: +55 (11) 3036-9988 +55 (11) 3036-9988

Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

The use of medications without proper guidance, through self-medication, can present health risks. Always seek the advice of a doctor. 

For questions or information, please contact customer services at 0800 771 0744 or email

Adverse event reporting: Use the link Notificação de Informação de Segurança or send an e-mail to

Medical Information:

Media Inquiries:


Biktarvy – Patient Information
Biktarvy – Information for Healthcare Professional


Epclusa – Patient Information
Epclusa – Information for Healthcare Professionals


Harvoni – Patient Information
Harvoni – Information for Healthcare Professionals

Official Note on Counterfeiting of Harvoni® Obtained through Direct Import

Gilead – Official Note on Counterfeit Harvoni


Sovaldi – Patient Information
Sovaldi – Information for Healthcare Professionals


Trodelvy – Patient Information
Trodelvy – Information for Healthcare Professionals


Truvada – Patient Information
Truvada – Information for Healthcare Professionals


Veklury – Patient Information

Veklury – Information for Healthcare Professionals


Vemlidy – Patient Information
Vemlidy – Information for Healthcare Professionals


Yescarta – Patient Information
Yescarta – Information for Healthcare Professionals

Authorized Distributors – Gilead Sciences Brasil

Medicine Distributor Phone Number Email/Website
Veklury® (remdesivir)
United Medical Ltda. 0800 770 5180
Truvada® (PrEP)
Specialty Pharma Goiás Ltda.
(SPG/SPL Pharma)
(11) 96059-4029
(11) 97407-5532
Trodelvy® Oncoprod

0800 017 0144
(11) 3026.9400 / (11) 2755.9400
(11) 4890-2001

Yescarta® - Cellular Therapy/CAR-T

Institutions qualified and authorized to administer the product in Brazil:

  • AC Camargo Câncer Center (SP)
  • Beneficência Portuguesa de São Paulo (SP)
  • Cancer Center Oncoclínicas Belo Horizonte – Hospital Oncobio (MG)
  • CHN - Complexo Hospitalar Niterói (RJ)
  • Hospital 9 de julho (SP)
  • Hospital Israelita Albert Einstein (SP)
  • Hospital Samaritano (SP)
  • Hospital São Luiz Itaim (SP)
  • Hospital São Rafael (BA)
  • Hospital Sírio Libanês (SP)
  • Hospital Vila Nova Star (SP)

Vemlidy® (tenofovir alafenamide)

Regarding the exceptional supply of the medicine with packaging materials and package insert in the English language

Gilead Sciences Farmacêutica do Brasil Ltda. (Gilead) clarifies that, in response to a request from the Ministry of Health and with a view to maintaining regular service to the public health network, as well as the continuity of Hepatitis B treatments, the batch of the drug Vemlidy® (tenofovir alafenamide) in the specifications described below, it will be supplied exceptionally with packaging materials and package insert in English.

To this end, the Ministry of Health submitted to the Health Surveillance Agency (ANVISA) a request for authorization, on an exceptional basis, for the import of the medicine Vemlidy® with packaging materials and package insert in the English language. This request was approved by the Agency's Collegiate Board of Directors in the Deliberative Circuit – CD 289/2024.

In the table below, Gilead details the batch and presentation description of the medicine involved in this exceptional authorization.

Vemlidy® (tenofovir alafenamide)

Batch Description of the presentation
042429 25 MG COM REV CT FR PLAS OPC X 30

It is also worth noting that Gilead has made copies of the package insert available in Portuguese so that the document can be supplied with the medicine bottles. Vemlidy® package insert can also be accessed through the ANVISA Electronic Information Sheet.

We remain at your disposal for any other information that may be necessary through the following channels:

This page is intended for visitors outside of the United States.